Naoki Terada

7PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 25, 2024
Expression of Podocalyxin Potentially Decorated With Low-sulfated Keratan Sulfate in Human Testicular Embryonal Carcinoma.

Akifumi Muramoto, Hitomi Hoshino, So Inamura

|Dec 26, 2023
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.

Akira Yokomizo, Masaki Shiota, Futoshi Morokuma

|Sep 07, 2023
Paradoxical Expression of R-10G-reactive Antigen in Human Testicular Embryonal Carcinoma.

Akifumi Muramoto, So Inamura, Hitomi Hoshino

|Nov 14, 2022
The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan.

Naoki Terada, Atsuro Sawada, Hiroaki Kawanishi

|Jun 24, 2022
Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis.

Shoichiro Mukai, Naotaka Sakamoto, Hiroaki Kakinoki

|Apr 27, 2022
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer.

Naoki Terada, Takashi Mizowaki, Toshihiro Saito

Pageof 2

Frequent Collaborators

2 joint publications

Masaki Shiota

2 joint publications

Kohei Hashimoto

2 joint publications

So Inamura

2 joint publications

Motohiro Kobayashi